33 results on '"Robaszkiewicz M"'
Search Results
2. P.321 Incidence de l’adénocarcinome du pancréas dans le département du Finistère entre 1990 et 2004 et survie des malades
- Author
-
Le Coadou, G., primary, Bessaguet, C., additional, Faycal, J., additional, Cauvin, J.M., additional, Robaszkiewicz, M., additional, Gouerou, H., additional, and Nousbaum, J.B., additional
- Published
- 2009
- Full Text
- View/download PDF
3. P. 184 Incidence et survie des carcinomes du cardia et de l’estomac dans le département du Finistère entre 1984 et 2003
- Author
-
Jezequel, J., primary, Bessaguet, C., additional, Faycal, J., additional, Volant, A., additional, Cauvin, J.M., additional, Verveur, C., additional, Nousbaum, J.B., additional, Gouerou, H., additional, and Robaszkiewicz, M., additional
- Published
- 2009
- Full Text
- View/download PDF
4. Prevalence and topography of intestinal metaplasia in columnar lined esophagus.
- Author
-
Jego M, Volant A, Faycal J, Doucet L, Andlauer E, Delalande AH, Cholet F, Nousbaum JB, Gouérou H, and Robaszkiewicz M
- Subjects
- Adult, Aged, Biopsy, Female, Humans, Male, Metaplasia epidemiology, Middle Aged, Prevalence, Barrett Esophagus pathology, Esophagus pathology, Intestines pathology
- Abstract
Objectives: Barrett's mucosa is considered as a mosaic of three epithelial types but little is known about the topography of intestinal metaplasia in columnar lined esophagus. The aims of the study were to determine the prevalence of intestinal metaplasia within long and short segments of columnar lined esophagus and to analyze the distribution of the intestinal metaplasia within long segments of Barrett's esophagus., Patients and Methods: The study was performed on the initial endoscopy carried out among 112 patients enrolled in an endoscopic surveillance program. Seventy-two patients with columnar mucosa extending more than 3 cm into the esophagus (group I) and 40 patients with a short segment of columnar mucosa (group II) had multiple biopsies according to a standardized protocol. 1163 biopsies were analyzed on the whole: 949 biopsies in group I and 214 biopsies in group II., Results: Intestinal metaplasia was identified among 650 (68.5%) and 50 (23.4%) biopsies in groups I and II respectively (P<10-7). The proportion of biopsies with foci of intestinal metaplasia increased significantly with the length of the columnar mucosa. The diagnosis of Barrett's esophagus was confirmed in 100% of the patients in group I and in 45% of the patients in group II. In long segments of Barrett's esophagus, intestinal metaplasia was more frequently observed in the 2 upper thirds of the columnar mucosa that in the lower third (P<10-7). Detailed mapping of the distribution of epithelial types within the columnar lined esophagus identified three patterns of distribution of intestinal metaplasia within long segments of Barrett's esophagus: unifocal, multifocal and diffuse, in 5%, 56% and 39% of the patients respectively. Dysplasia was present in 15% of patients with long segments of Barrett's esophagus and 11% of patients with short segments (NS)., Conclusion: The distribution of intestinal metaplasia within columnar lined esophagus is heterogeneous and three distinct patterns can be identified: unifocal, multifocal and diffuse. Considering the risk of sampling error, the current recommendations concerning the biopsy protocols are mandatory until the validation of new techniques such as chromoendoscopy or magnifying endoscopy.
- Published
- 2007
- Full Text
- View/download PDF
5. Epidemiology of hepatocellular carcinoma in Finistère. Prospective study from June 2002 to May 2003.
- Author
-
Caumes JL, Nousbaum JB, Bessaguet C, Fayçal J, Robaszkiewicz M, and Gouérou H
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Catheter Ablation statistics & numerical data, Chemoembolization, Therapeutic statistics & numerical data, Female, France epidemiology, Hepatectomy statistics & numerical data, Humans, Incidence, Liver Cirrhosis, Alcoholic epidemiology, Male, Mass Screening statistics & numerical data, Middle Aged, Population Surveillance, Prospective Studies, Sex Factors, Carcinoma, Hepatocellular epidemiology, Liver Neoplasms epidemiology
- Abstract
Objectives: The aims of this prospective study were to evaluate the incidence of hepatocellular carcinoma (HCC) in Finistère, an administrative district of western France, and to highlight epidemiological characteristics., Methods: From June 1st 2002 to May 31st 2003, all cases of HCC in Finistère were registered prospectively. Standardized incidence rates were calculated., Results: One hundred and six cases of HCC were registered. Standardized incidence rates were 13.8/100000 among men and 0.8/100000 among women. Among the incident cases of HCC, 52% were discovered in patients consulting for symptoms, and 28% in patients undergoing screening. The new non-invasive diagnostic criteria of HCC were used in 60% of cases. HCC was associated with cirrhosis in 89 patients (84%). Excessive alcohol intake was the main cause of cirrhosis. In all, 27 patients (25.5%) received potentially curative treatment., Conclusion: Incidence of HCC is high in Finistère. The proportion of patients given potentially curative treatment is still low, illustrating how difficult screening can be when alcoholic cirrhosis predominates in the target population.
- Published
- 2007
- Full Text
- View/download PDF
6. [Treatment of squamous cell carcinoma of the pancreas with gemcitabine].
- Author
-
Bideau K, Metges JP, Bayle S, André M, Robaszkiewicz M, Lagarde N, and Labat JP
- Subjects
- Aged, Aged, 80 and over, Antimetabolites, Antineoplastic administration & dosage, Biopsy, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell radiotherapy, Carcinoma, Squamous Cell secondary, Carcinoma, Squamous Cell surgery, Combined Modality Therapy, Deoxycytidine administration & dosage, Deoxycytidine therapeutic use, Humans, Liver pathology, Liver Neoplasms drug therapy, Liver Neoplasms mortality, Liver Neoplasms pathology, Liver Neoplasms secondary, Male, Middle Aged, Pancreatic Neoplasms mortality, Pancreatic Neoplasms radiotherapy, Pancreatic Neoplasms surgery, Prognosis, Time Factors, Treatment Outcome, Gemcitabine, Antimetabolites, Antineoplastic therapeutic use, Carcinoma, Squamous Cell drug therapy, Deoxycytidine analogs & derivatives, Pancreatic Neoplasms drug therapy
- Abstract
Primary squamous cell carcinoma of the pancreas is a rare tumor. We report a case of a 49 years old patient with a metastatic squamous cell carcinoma of the pancreas. Histological diagnosis was established by echoguided biopsy of the liver. Due to that, we cannot be sure that this tumor was not adenosquamous with a metastatic component from only the squamous part of the lesion. Two types of chemotherapy have been performed. The first one was radiochemotherapy with an association of 5FU and cisplatinum. Gemcitabin was the second one. An objective response was obtained with gemcitabin and the patient's health improved. To our knowledge, this has never had been reported beforehand. However the prognosis of this cancer remains poor. Overall survival was 8 months.
- Published
- 2006
- Full Text
- View/download PDF
7. Validation of the short-form REFLUX-QUAL (RQS), a gastro-esophageal reflux disease (GERD) specific quality of life questionnaire.
- Author
-
Amouretti M, Nalet B, Robaszkiewicz M, Wainsten JP, de la Loge C, Benmedjahed K, Dias-Barbosa C, Brin S, and Schatz B
- Subjects
- Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Psychometrics, Reproducibility of Results, Gastroesophageal Reflux psychology, Quality of Life, Surveys and Questionnaires
- Abstract
Introduction: Being an easy-to-use (eight items) quality of life questionnaire specific to GERD, the Reflux-Qual Short form (RQS) was developed for use in everyday practice. The purpose of this study was to assess the psychometric properties of the RQS., Methods and Materials: The reliability of the RQS was measured by the Cronbach's alpha coefficient and its clinical validity by comparing the RQS score for increasing clinical severity groups. The RQS discriminative power was compared with that of the SF12. Sensitivity to change over time was measured by calculating effect-sizes., Results: The reliability and validity of the questionnaire were assessed on a sample of 1195 patients. Its psychometric properties were very satisfactory: Cronbach alpha = 0.84; RQS score significantly reduced for the worst-affected patients; the discriminative power was up to 5 times higher when compared with the SF-12. Sensitivity to change over time, evaluated with 362 patients, showed highly significant differences between groups with different levels of clinical progression (P = 0.0001)., Conclusion: The RQS is a quality of life measurement instrument specific to GERD which is short, reliable, valid, and sensitive to within and between-subject differences.
- Published
- 2005
- Full Text
- View/download PDF
8. Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995.
- Author
-
Fayçal J, Bessaguet C, Nousbaum JB, Cauvin JM, Cholet F, Bideau K, Robaszkiewicz M, and Gouérou H
- Subjects
- Adult, Aged, Aged, 80 and over, Female, France epidemiology, Humans, Male, Middle Aged, Multivariate Analysis, Survival Rate, Time Factors, Stomach Neoplasms epidemiology, Stomach Neoplasms surgery
- Abstract
Objectives: The aims of this study were to evaluate trends in incidence, clinical characteristics, treatment regimen and prognosis of gastric carcinoma in the area of Finistere (France) during a 12-year period., Methods: Between 1984 and 1995, the Finistere Registry of GastroIntestinal Tract Tumors listed 2 139 patients with gastric carcinoma in a population of 838 627 inhabitants. Curative resection and operative mortality were analyzed by logistic regression. Prognostic factors were determined using the Kaplan-Meier method and the Cox model., Results: When comparing the second period (1990-1995) to the first period (1984-1989) we observed: a) a decrease of standardized incidence (13.2 vs. 15.6/100 000 inhabitants/year in males and 5.4 vs. 7.0/100 000 inhabitants/year in females); b) a significant increase of linitis plastica (21.4% vs. 10.9%) and infiltrative tumors (53.1 vs. 31.2%) (P<0.0001); c) no variation in tumor stage at diagnosis; d) a significant increase in curative resection (65.7% vs. 45.0%; P<0.0001); e) no variation in operative mortality; f) the absence of improvement of survival rate; the latter was 29% at 2 years, 19% at 5 years and 11% at 10 years during the second period. Multivariate analysis showed that the main prognostic factors of gastric carcinoma were age, tumor stage and the type of surgical procedure., Conclusion: This study showed a decrease in the incidence of gastric carcinoma over time and an increase of linitis plasticia and infiltrative forms. Despite improvement in management of patients, the global prognosis of gastric carcinoma did not improve significantly over a 12-year period of observation.
- Published
- 2005
- Full Text
- View/download PDF
9. [Precancerous lesions of the esophagus].
- Author
-
Robaszkiewicz M
- Subjects
- Adenocarcinoma etiology, Barrett Esophagus complications, Carcinoma, Squamous Cell etiology, Decision Trees, Esophageal Neoplasms diagnosis, Esophagus pathology, Humans, Mucous Membrane pathology, Risk Factors, Esophageal Neoplasms etiology, Precancerous Conditions diagnosis, Precancerous Conditions etiology, Precancerous Conditions therapy
- Published
- 2004
- Full Text
- View/download PDF
10. [Barrett's esophagus].
- Author
-
Robaszkiewicz M and Cholet F
- Subjects
- Cell Transformation, Neoplastic, Diagnosis, Differential, Endoscopy, Gastrointestinal, Humans, Patient Care Planning, Risk Factors, Barrett Esophagus complications, Barrett Esophagus diagnosis, Barrett Esophagus pathology, Esophageal Neoplasms etiology
- Published
- 2004
- Full Text
- View/download PDF
11. Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.
- Author
-
Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, and Gouérou H
- Subjects
- Adult, Alcoholism complications, Cohort Studies, Fatty Liver physiopathology, Female, Genotype, Hepatitis C, Chronic genetics, Humans, Liver Cirrhosis physiopathology, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Risk Factors, Fatty Liver etiology, Hepatitis C, Chronic complications, Hepatitis C, Chronic physiopathology, Liver Cirrhosis etiology
- Abstract
Unlabelled: Liver steatosis is a common finding in patients infected with hepatitis C virus (HCV). Host and viral factors have been associated with steatosis, but their relative contributions have not been clearly addressed. It has been suggested that steatosis plays a role in the progression of liver fibrosis., Aims: To assess: a) factors associated with steatosis in patients infected with hepatitis C virus; b) their impact on liver fibrosis., Patients and Methods: Three hundred and fourteen untreated patients were included. Lifetime alcohol consumption was estimated. Liver fibrosis, inflammation and necrosis were assessed using the METAVIR score. Body mass index (BMI) was determined. The scoring system for steatosis was as follows: 0, no steatosis; 1, less than 10%; 2, 10% to 30%; 3, 30% to 70%; 4, more than 70% of hepatocytes affected., Results: In univariate analysis, steatosis was associated with elevated BMI (P=0.001), excessive alcohol intake (P=0.005), genotype 3 (P<0.001) and moderate to severe histological activity (P=0.01). Multivariate analysis showed that steatosis correlated with two independent factors: genotype 3a (OR=60.7; 95% CI: 7.6-483.4) (P<0.001) and BMI (OR=4.86; 95% CI: 1.8-13.15) (P=0.002). In univariate analysis, severe fibrosis (F2-F3-F4) was associated with older age (P<10(-5)), male gender (P=0.001), disease duration (P<0.006), BMI (P<10(-4)), alcohol intake (P<10(-6)), severity of histological activity (P<10(-5)) and steatosis (P<10(-6)). In multivariate analysis, three independent factors were associated with severe fibrosis: disease duration > 10 years (OR=3.17; 95% CI: 0.65-15.4) (P=0.015), presence of steatosis (OR=3.17; 95% CI: 1-9.99) (P<0.049) and genotype 3a (OR=5.56; 95% CI: 1.4-22.1) (P=0.015)., Conclusion: In patients with chronic hepatitis C, steatosis is significantly associated with genotype 3 infection and high BMI. Steatosis is an independent risk factor associated with severe fibrosis. These results have major implications for the management of patients with chronic hepatitis C.
- Published
- 2004
- Full Text
- View/download PDF
12. [Adenocarcinoma of the esophago-gastric junction arising after endoscopic laser photocoagulation ablation of the short segment of Barrett's esophagus].
- Author
-
Macey N, Le Dréau G, Volant A, Vaucher C, Nousbaum JB, Gouérou H, and Robaszkiewicz M
- Subjects
- Adenocarcinoma pathology, Aged, Barrett Esophagus complications, Barrett Esophagus diagnosis, Biopsy, Cell Transformation, Neoplastic, Esophageal Neoplasms pathology, Esophagoscopy methods, Gastroesophageal Reflux etiology, Humans, Laser Coagulation methods, Male, Pain etiology, Stomach Neoplasms pathology, Adenocarcinoma etiology, Barrett Esophagus surgery, Esophageal Neoplasms etiology, Esophagogastric Junction, Esophagoscopy adverse effects, Laser Coagulation adverse effects, Stomach Neoplasms etiology
- Published
- 2001
13. [Angina-like chest pain: physiopathology, diagnostic measure and treatment].
- Author
-
Robaszkiewicz M, Giroux MA, and Nousbaum JB
- Subjects
- Diagnosis, Differential, Esophagus, Humans, Hydrochloric Acid, Hydrogen-Ion Concentration, Manometry, Angina Pectoris diagnosis, Angina Pectoris physiopathology, Angina Pectoris therapy, Chest Pain etiology, Chest Pain physiopathology, Chest Pain therapy
- Published
- 2000
14. [Surveillance of Barrett esophagus].
- Author
-
Robaszkiewicz M
- Subjects
- Adenocarcinoma mortality, Barrett Esophagus surgery, Biopsy, Cell Transformation, Neoplastic, Esophageal Neoplasms mortality, Follow-Up Studies, Humans, Precancerous Conditions, Risk Factors, Barrett Esophagus pathology
- Published
- 1999
15. [Recurrent auto-immune thrombopenic purpura during a severe attack of ulcerative colitis].
- Author
-
Vaucher C, Bideau K, Nousbaum JB, Sensebé L, Février L, Robaszkiewicz M, and Gouérou H
- Subjects
- Acute Disease, Adult, Anti-Inflammatory Agents therapeutic use, Female, Humans, Methylprednisolone therapeutic use, Purpura, Thrombocytopenic, Idiopathic diagnosis, Purpura, Thrombocytopenic, Idiopathic drug therapy, Recurrence, Colitis, Ulcerative complications, Purpura, Thrombocytopenic, Idiopathic etiology
- Published
- 1998
16. [Diagnosis of mediastinal neuro-endocrine tumor using endosonography guided transesophageal puncture biopsy].
- Author
-
Le Dreau G, Calament G, Volant A, Savary O, Cauvin JM, Robaszkiewicz M, and Gouerou H
- Subjects
- Esophagus, Fatal Outcome, Humans, Male, Middle Aged, Biopsy, Needle methods, Endosonography, Mediastinal Neoplasms pathology, Neuroendocrine Tumors pathology
- Abstract
Histologic diagnosis of tumors of the mediastinum is mandatory for therapeutic management. The location and the variety of tumors are responsible for diagnostic difficulties. Endosonography guided fine-needle biopsy is an efficient and safe procedure for the diagnosis of peridigestive masses. We report the case of a patient with a neuroendocrine tumor of the mediastinum revealed by a mass syndrome. The diagnosis was performed by endosonography guided needle biopsy.
- Published
- 1998
17. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
- Author
-
Pagenault M, Tron I, Alexandre JL, Cruchant E, Dabadie A, Chaperon J, Robaszkiewicz M, and Bretagne JF
- Subjects
- Acute Disease, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Chronic Disease, Colitis epidemiology, Colitis, Ulcerative epidemiology, Crohn Disease epidemiology, Female, France epidemiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, Registries, Inflammatory Bowel Diseases epidemiology
- Abstract
Objectives: The aim of the study was to determine the incidence and the main clinical data of inflammatory bowel disease in Brittany., Methods: According to EPIMAD registry's methodology, private and public gastroenterologists (n = 139) of Brittany (2836418 inhabitants) referred all patients consulting for the first time, in 1994 and 1995 with clinical symptoms compatible with inflammatory bowel disease. An interviewer practitioner completed at the gastroenterologist's consulting room a standard questionnaire for each patient. Each case was reviewed separately by four experts to assign a diagnosis of definite, probable, possible Crohn's disease, ulcerative colitis, unclassifiable chronic colitis, or acute colitis (onset of symptoms < 6 weeks)., Results: 657 cases were recorded: 205 Crohn's disease (31%), 165 ulcerative colitis (25%) including 75 ulcerative proctitis (46%), 42 unclassifiable chronic colitis (7%), 245 acute colitis (37%). The crude mean annual incidence (per 10(5) inhabitants) based on definite and probable cases only was 2.8 for Crohn's disease and 2.9 for ulcerative colitis. The female/male ratio was 0.9 for Crohn's disease and 0.5 for ulcerative colitis. The median age at time of diagnosis was 27 for Crohn's disease and 36 for ulcerative colitis. The median time between onset of symptoms and diagnosis was equal to 3 months for Crohn's disease and ulcerative colitis., Conclusion: In Brittany the observed incidence of ulcerative colitis is similar to that of Crohn's disease and close to that observed in northern France. The incidence of Crohn's disease is lower. However, the real incidence of inflammatory bowel disease is currently underestimated due to the large number of acute colitis requiring a follow up and the cases of Crohn's disease classified as possible not taken into account.
- Published
- 1997
18. [From Barrett esophagus to adenocarcinoma: can the dangers of natural history be overcome?].
- Author
-
Robaszkiewicz M
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma prevention & control, Barrett Esophagus pathology, Barrett Esophagus physiopathology, Biomarkers, Tumor, Esophageal Neoplasms diagnosis, Esophageal Neoplasms prevention & control, Humans, Time Factors, Adenocarcinoma etiology, Barrett Esophagus complications, Esophageal Neoplasms etiology
- Published
- 1996
19. [Severe forms of Mallory-Weiss syndrome].
- Author
-
Carré D, Metges JP, Nousbaum JB, Cauvin JM, Gouerou H, and Robaszkiewicz M
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Mallory-Weiss Syndrome complications
- Published
- 1996
20. [Therapeutic management and survival of gastric adenocarcinoma in the province of Finistère between 1984 and 1989].
- Author
-
Le Page M, Cauvin JM, Le Dréau G, Nousbaum JB, Enard L, Gourlaouen A, Robaszkiewicz M, and Gouérou H
- Subjects
- Adenocarcinoma surgery, Adenocarcinoma therapy, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Combined Modality Therapy, Endoscopy, Gastrointestinal, Female, Follow-Up Studies, France epidemiology, Gastrectomy, Humans, Male, Middle Aged, Prognosis, Stomach Neoplasms surgery, Stomach Neoplasms therapy, Adenocarcinoma mortality, Stomach Neoplasms mortality
- Abstract
Objectives: The aim of this study was to analyze the evolution of treatment regimens and survival rates of stomach adenocarcinoma recorded in the Finistère cancer registry from 1984 to 1989., Methods: In a population of 838,627 inhabitants, 1,280 patients with a gastric cancer were registered; 1,164 patients (693 males and 471 females) had an adenocarcinoma. Survival rates were estimated by the actuarial method, and compared using the logrank test and the Cox model., Results: Surgical resection was the main treatment for 661 patients (57%). The frequency of curative resection increased from 25% between 1984 and 1986 to 35% after 1986. Among the other patients, 39 (3%) were treated by chemotherapy and/or radiotherapy, and 53 patients (4%) by endoscopy alone; 253 patients had only symptomatic treatment. The survival rates of all patients were 43% at 1 year and 20% at 5 years. The median survival was 9.2 +/- 0.6 months. In patients with cancer managed surgically, the factors associated with a better prognosis were young age, long duration of symptoms before diagnosis, ulcerated macroscopic aspect, limited tumour extension and curative surgical resection. In other patients, 2 factors were associated a with better prognosis: the absence of metastases and an endoscopic palliative treatment., Conclusions: Surgical resection is the main treatment of gastric adenocarcinoma. Although the frequency of surgery increased, the prognosis of gastric adenocarcinoma did not improve within this 6-year period.
- Published
- 1995
21. [Overexpression of protein p53 and Barrett esophagus. A frequent and early event in the course of carcinogenesis].
- Author
-
Fléjou JF, Volant A, Diebold MD, Sagan C, Vissuzaine C, Croué A, Robaszkiewicz M, and Potet F
- Subjects
- Barrett Esophagus complications, Barrett Esophagus surgery, Cell Transformation, Neoplastic, Esophageal Neoplasms etiology, Esophageal Neoplasms pathology, Esophageal Neoplasms surgery, Esophagectomy, Humans, Immunohistochemistry, Time Factors, Barrett Esophagus genetics, Esophageal Neoplasms genetics, Tumor Suppressor Protein p53 genetics
- Abstract
Objectives and Methods: In Barrett's oesophagus, the risk of malignancy is evaluated histologically with the presence of dysplasia. The abnormal expression of p53 protein could represent a useful new marker. The aim of this study was evaluate the abnormal expression of p53 protein in a series of 52 oesophagectomy specimens with Barrett's oesophagus, either non-dysplastic (n = 3), dysplastic (n = 8), or malignant (n = 41). The immunohistochemical study was made on deparaffinized sections with the monoclonal anti-p53 antibody DO7., Results: The 3 non-dysplastic cases were p53 negative; 1 case of low-grade dysplasia in 5 was positive, as were the 3 cases of high grade dysplasia and 33 of 41 cancers (80%), including 13 superficial cancers in 14 (93%) and 20 invasive cancers in 27 (74%). A common feature was the presence of rare p53 positive crypts in low grade dysplastic areas and non-dysplastic specialized mucosa that surrounded high grade dysplasia and cancers., Conclusions: Our results confirm the high frequency of the abnormal expression of p53 protein in cancer developed in Barrett's oesophagus. This expression is a consequence of alterations of the TP53 gene, and has an important role in the carcinogenesis of Barrett's mucosa; it is likely to represent an early event. Prospective studies are needed to evaluate its interest in the surveillance of patients with Barrett's oesophagus.
- Published
- 1995
22. [Value of the analysis of DNA cellular content by flow cytometry in Barrett esophagus].
- Author
-
Robaszkiewicz M, Hardy E, and Volant A
- Subjects
- Adenocarcinoma etiology, Barrett Esophagus complications, Cell Transformation, Neoplastic, DNA, Neoplasm analysis, Esophageal Neoplasms etiology, Humans, Precancerous Conditions genetics, Adenocarcinoma genetics, Barrett Esophagus genetics, DNA analysis, Esophageal Neoplasms genetics, Flow Cytometry methods
- Published
- 1994
23. [Changes in the TP53 tumor suppressor gene in malignant transformation of Barrett esophagus].
- Author
-
Ferec C, Audrezet MP, Mercier B, and Robaszkiewicz M
- Subjects
- Adenocarcinoma etiology, Barrett Esophagus complications, Esophageal Neoplasms etiology, Humans, Adenocarcinoma genetics, Barrett Esophagus genetics, Esophageal Neoplasms genetics, Genes, p53 genetics, Tumor Suppressor Protein p53 genetics
- Published
- 1994
24. [Relationship between Barrett esophagus and colorectal tumors].
- Author
-
Cauvin JM, Goldfain D, Le Rhun M, Robaszkiewicz M, Cadiot G, Carpentier S, Rotenberg A, Mignon M, Boyer J, and Galmiche JP
- Subjects
- Adenoma etiology, Adult, Age Factors, Aged, Aged, 80 and over, Colorectal Neoplasms etiology, Female, Humans, Male, Middle Aged, Prevalence, Sex Factors, Adenoma epidemiology, Barrett Esophagus complications, Colorectal Neoplasms epidemiology
- Published
- 1994
25. [Barrett's mucosa. From metaplasia ... to cancer].
- Author
-
Fléjou JF and Robaszkiewicz M
- Subjects
- Humans, Adenocarcinoma etiology, Barrett Esophagus complications, Esophageal Neoplasms etiology
- Published
- 1994
26. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
- Author
-
Robaszkiewicz M, Volant A, Hardy E, Nousbaum JB, Calament G, Cauvin JM, Bail JP, Lozach P, and Gouerou H
- Subjects
- Adenocarcinoma etiology, Adenocarcinoma pathology, Barrett Esophagus complications, Barrett Esophagus pathology, Biopsy, DNA, Neoplasm genetics, Esophageal Neoplasms etiology, Esophageal Neoplasms pathology, Humans, Adenocarcinoma genetics, Barrett Esophagus genetics, DNA, Neoplasm analysis, Esophageal Neoplasms genetics, Flow Cytometry methods
- Abstract
Flow cytometry was used to examine the spatial distribution of nuclear DNA content in Barrett's mucosa, in one patient with high grade dysplasia and in 6 patients with Barrett's adenocarcinoma. All tumors were aneuploid. Each adenocarcinoma but the most advanced seemed to arise from a single clone of aneuploid or near-tetraploid cells which was found in all biopsy specimens taken from the tumor. Multiple aneuploid populations of cells were seen in the larger tumors. Eight clones were individualized in the most advanced case of cancer. In all patients with carcinoma, the mucosa surrounding the tumor was aneuploid. Some areas were characterized by the same DNA index as in the tumor, others contained distinct aneuploid cell populations. The spatial distributions of aneuploid clones and dysplastic areas were not perfectly superimposed. These data suggest that neoplastic progression in Barrett's esophagus is associated with genomic instability preceding the development of malignancy. Clonal heterogeneity in Barrett's adenocarcinoma is more marked when compared to other tumors and suggests a majoration of genomic instability during tumor progression.
- Published
- 1992
27. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].
- Author
-
Robaszkiewicz M, Hardy E, Volant A, Nousbaum JB, Cauvin JM, Calament G, Robert FX, Saleun JP, and Gouerou H
- Subjects
- Adenocarcinoma pathology, Adult, Aged, Aged, 80 and over, Barrett Esophagus complications, Barrett Esophagus pathology, Biopsy, Esophageal Neoplasms pathology, Female, G2 Phase, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, S Phase, Adenocarcinoma etiology, Barrett Esophagus genetics, DNA analysis, Esophageal Neoplasms etiology, Flow Cytometry methods
- Abstract
Dysplasia is the only marker for malignant potential in Barrett's esophagus. The histologic interpretation of dysplasia is sometimes difficult, particularly when attempting to distinguish dysplastic changes from those of a regenerating and inflammatory mucosa. In order to find an objective marker to identify patients with high risk of malignant transformation, the authors evaluated 497 biopsies from 66 patients with Barrett's esophagus with flow cytometry. The aim of the study was to correlate DNA content and proliferative abnormalities with histology. All biopsies classified histologically as negative for dysplasia had a diploid DNA content. The percentage of biopsies with an aneuploid DNA content increased with the histologic grade of dysplasia: 2 percent of indefinite dysplasia, 11 percent of low grade dysplasia, 44 percent of high grade dysplasia and 78 percent of biopsy specimens with cancer biopsies were aneuploid. Mean S and G2M fractions of diploid biopsy specimens increased with the severity of histologic changes. The S and G2M fraction threshold values that could differentiate patients that were negative for dysplasia from those with high grade dysplasia or cancer were 9 percent and 6 percent, respectively. Aneuploidy or G2M fraction greater than 6 percent was the best discriminating criteria between those two distinct groups of patients. All 6 patients with high grade dysplasia or cancer had aneuploid cell populations or increased G2M fraction, whereas none of the 35 patients whose biopsies were histologically negative for dysplasia had evidence of genomic instability or increased G2M fraction. Flow cytometric abnormalities were found in 10 out of 25 patients whose biopsies were classified as indefinite for dysplasia or low grade dysplasia.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1991
28. [Polypoid pseudosarcomatous carcinoma of the esophagus. Report of two cases with favorable outcome after medical treatment].
- Author
-
Robaszkiewicz M, Volant A, Guez C, Benzenou A, and Gouerou H
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma diagnostic imaging, Carcinoma pathology, Combined Modality Therapy, Endoscopy, Digestive System methods, Esophageal Neoplasms diagnostic imaging, Esophageal Neoplasms pathology, Humans, Male, Middle Aged, Radiography, Treatment Outcome, Carcinoma therapy, Esophageal Neoplasms therapy
- Abstract
The authors report two cases of esophageal polypoid pseudosarcoma with favorable outcome after endoscopic and medical treatment. Neither of the two patients could undergo general anesthesia. Endoscopic resection or monopolar electrocoagulation of the tumor was associated with chemotherapy and radiation therapy. A complete response of the tumor was observed in both cases. The two patients were alive and well with no evidence of recurrence or metastasis 3 and 5 years after diagnosis. Immunohistochemical study of those two tumors with monoclonal antibodies to intermediate filaments (keratin and vimentin) suggests duality in the spindle cell component. It may explain the biological behaviour of these particular cancers that have a better prognosis than other types of squamous cell carcinomas of the esophagus.
- Published
- 1991
29. [Pancreatic sarcoidosis].
- Author
-
Robaszkiewicz M, Cauvin JM, Nousbaum JB, Geier B, Volant A, and Gouerou H
- Subjects
- Acute Disease, Adrenal Cortex Hormones therapeutic use, Adult, Cholangiopancreatography, Endoscopic Retrograde, Humans, Male, Pancreatitis therapy, Prognosis, Pancreatic Diseases etiology, Sarcoidosis complications
- Abstract
The authors report the case of a 30 year-old man with previous history of sarcoidosis, who presented with a painful infiltration of the pancreas. A review of the literature showed that symptomatic pancreatic sarcoidosis was uncommon, since only 8 other cases have been reported. Pancreatic involvement is frequently associated with hepatic infiltration (5/6 cases). Exocrine or endocrine dysfunction are possible. Diagnosis is made only at exploratory laparotomy. Prognosis is good. Steroid therapy is indicated in this peculiar type of pancreatitis, because of its long-range effectiveness on the outcome of the disease.
- Published
- 1989
30. [Gastroduodenal necrosis in an hemolytic and uremic syndrome in the adult].
- Author
-
Garo B, Geier B, Le Guillou M, Robaszkiewicz M, Hervé JP, Volant A, Cledes J, Gouerou H, and Leroy JP
- Subjects
- Aged, Duodenal Diseases pathology, Female, Humans, Stomach Diseases pathology, Duodenal Diseases etiology, Hemolytic-Uremic Syndrome complications, Necrosis etiology, Stomach Diseases etiology
- Published
- 1988
31. [Intraoperative radiotherapy in digestive oncology].
- Author
-
Bail JP, Etienne J, Robaszkiewicz M, Malhaire JP, Lozac'h P, Gouerou H, Labat JP, and Charles JF
- Subjects
- Adenocarcinoma surgery, Combined Modality Therapy, Digestive System Neoplasms surgery, Humans, Intraoperative Period, Pancreatic Neoplasms radiotherapy, Pancreatic Neoplasms surgery, Rectal Neoplasms radiotherapy, Rectal Neoplasms surgery, Stomach Neoplasms radiotherapy, Stomach Neoplasms surgery, Adenocarcinoma radiotherapy, Digestive System Neoplasms radiotherapy
- Published
- 1989
32. [M cell and lymphoid follicle associated epithelium of the digestive tract].
- Author
-
Robaszkiewicz M, Jarry A, Brousse N, and Potet F
- Subjects
- Animals, Digestive System immunology, Epithelial Cells, Epithelium immunology, Humans, Intestinal Mucosa cytology, Intestinal Mucosa immunology, Lymphocytes immunology, Microscopy, Electron, Peyer's Patches cytology, Peyer's Patches ultrastructure, Digestive System cytology
- Published
- 1989
33. [Attempt at preventive treatment of esophagitis caused by intubation during intensive care].
- Author
-
Baccino E, Boles JM, Le Guillou M, Geier B, Garo B, Robaszkiewicz M, and Cleuziou A
- Subjects
- Adult, Aged, Esophagitis etiology, Female, Humans, Injections, Intravenous, Male, Middle Aged, Prospective Studies, Random Allocation, Resuscitation, Aluminum therapeutic use, Aluminum Compounds, Antacids therapeutic use, Cimetidine therapeutic use, Esophagitis prevention & control, Intubation, Gastrointestinal adverse effects, Phosphates therapeutic use
- Abstract
A randomized prospective trial was designed to evaluate the preventive treatment of esophagitis in 31 intensive care patients who had a nasogastric feeding tube for at least 10 days. Fourteen patients (group B) received no preventive treatment while 17 patients (group A) received 300 mg of cimetidine every 6 h intravenously and 11 g of colloidal aluminium phosphate every 4 h per os. All patients were fed a standard diet through their nasogastric tube at a constant rate of 30 Kcal/kg/day. Endoscopic controls at day 1 and 10 showed that the number of initial and final esophagitis was not different in groups B and A: 7 and 8 at day 1, 11 and 10 at day 10, respectively. The inefficiency of this preventive treatment suggested that acid gastroesophageal reflux is not a major factor in the occurrence of nasogastric feeding tube-induced esophagitis. However as esophagitis is associated with a more severe Knaus index and a greater number of gastric stress ulcer risk factors, it is suggested that decreased defense of the mucosa may be a key factor in the occurrence of this type of esophagitis.
- Published
- 1987
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.